Date Initiated by Firm |
December 07, 2022 |
Date Posted |
January 11, 2023 |
Recall Status1 |
Open3, Classified |
Recall Number |
Z-0949-2023 |
Recall Event ID |
91310 |
510(K)Number |
K982468
|
Product Classification |
System, test, thyroglobulin - Product Code MSW
|
Product |
IMMULITE 2000 Thyroglobulin (US)- For in vitro diagnostic use with the IMMULITE 2000 Systems Analyzers (IMMULITE 2000/ IMMULITE 2000 XPi) for the quantitative measurement of thyroglobulin in serum or heparinized plasma, as an aid in monitoring patients who have undergone thyroidectomy. Catalog # L2KTY2(D) Siemens Material Number (SMN): 10381647 |
Code Information |
UDI: 00630414972084
Kit Lots: D431, D433, D434, D435, and D436 |
Recalling Firm/ Manufacturer |
Siemens Healthcare Diagnostics, Inc. 511 Benedict Ave Tarrytown NY 10591-5005
|
For Additional Information Contact |
SAME 914-631-8000
|
Manufacturer Reason for Recall |
Potential for Functional Sensitivity to not meet Instructions For Use (IFU) claims with the kit lots;
control level one may result outside of published ranges;
when control results are in range, users may observe increased imprecision with low level patient samples
|
FDA Determined Cause 2 |
Under Investigation by firm |
Action |
Siemens Healthcare issued An Urgent Medical Device Correction (UMDC) to US affected customers by FedEx beginning 12/08/2022. An Urgent Field Safety Notice (UFSN) was issued to OUS Siemens reporting sites with affected customers, for distribution and regional reporting to their local competent authorities beginning on 12/07/2022.
Letter states reason for recall, health risk and action to take:
Discontinue use and discard Thyroglobulin kit lots listed in Table 1.
Please review this letter with your Medical Director, including consideration for review of previously generated results as outlined above in Risk to Health.
Complete and return Field Correction Effectiveness Check Form attached to this letter within 30 days.
Review your inventory of these products determine your laboratory s replacement needs and to provide information to Siemens Healthineers for reporting to the authorities.
If you have received any complaints of illness or adverse events associated with the products listed in Table 1, immediately contact your local Siemens Healthineers Customer Care Center or your local Siemens Healthineers technical support representative.
Please retain this letter with your laboratory records and forward this letter to those who may have received this product. If you have any questions, please contact your Siemens Healthineers Customer Care Center or your local Siemens Healthineers technical support representative.
|
Quantity in Commerce |
717 kits |
Distribution |
Nationwide
Foreign:
Argentina¿¿¿¿¿¿
Australia¿¿¿¿¿¿
Austria¿¿¿¿¿¿¿¿
Bahrain¿¿¿¿¿¿¿¿
Bangladesh¿¿¿¿¿
Belgium¿¿¿¿¿¿¿¿
Bolivia¿¿¿¿¿¿¿¿
Bosnia¿Herzeg.¿
Brazil¿¿¿¿¿¿¿¿¿
Bulgaria¿¿¿¿¿¿¿
Canada¿¿¿¿¿¿¿¿¿
Chile¿¿¿¿¿¿¿¿¿¿
Colombia¿¿¿¿¿¿¿
Costa¿Rica¿¿¿¿¿
Croatia¿¿¿¿¿¿¿¿
Cyprus¿¿¿¿¿¿¿¿¿
Czech¿Republic¿
Dominican¿Rep.¿
Ecuador¿¿¿¿¿¿¿¿
Egypt¿¿¿¿¿¿¿¿¿¿
Estonia¿¿¿¿¿¿¿¿
Finland¿¿¿¿¿¿¿¿
France¿¿¿¿¿¿¿¿¿
Georgia¿¿¿¿¿¿¿¿
Germany¿¿¿¿¿¿¿¿
Greece¿¿¿¿¿¿¿¿¿
Honduras¿¿¿¿¿¿¿
Hong¿Kong¿¿¿¿¿¿
Hungary¿¿¿¿¿¿¿¿
India¿¿¿¿¿¿¿¿¿¿
Indonesia¿¿¿¿¿¿
Iran¿¿¿¿¿¿¿¿¿¿¿
Iraq¿¿¿¿¿¿¿¿¿¿¿
Ireland¿¿¿¿¿¿¿¿
Israel¿¿¿¿¿¿¿¿¿
Italy¿¿¿¿¿¿¿¿¿¿
Jordan¿¿¿¿¿¿¿¿¿
KA
Kazakhstan¿¿¿¿¿
Kosovo¿¿¿¿¿¿¿¿¿
Kyrgyzstan¿¿¿¿¿
Latvia¿¿¿¿¿¿¿¿¿
Lithuania¿¿¿¿¿¿
Macedonia¿¿¿¿¿¿
Malaysia¿¿¿¿¿¿¿
Mexico¿¿¿¿¿¿¿¿¿
Morocco¿¿¿¿¿¿¿¿
Nepal¿¿¿¿¿¿¿¿¿¿
Netherlands¿¿¿¿
P.R.¿China¿¿¿¿¿
Pakistan¿¿¿¿¿¿¿
Panama¿¿¿¿¿¿¿¿¿
Paraguay¿¿¿¿¿¿¿
Peru¿¿¿¿¿¿¿¿¿¿¿
Philippines¿¿¿¿
Poland¿¿¿¿¿¿¿¿¿
Portugal¿¿¿¿¿¿¿
Republic¿Korea¿
Romania¿¿¿¿¿¿¿¿
Russian¿Fed.¿¿¿
Saudi¿Arabia¿¿¿
Serbia¿¿¿¿¿¿¿¿¿
Singapore¿¿¿¿¿¿
Slovakia¿¿¿¿¿¿¿
Slovenia¿¿¿¿¿¿¿
South¿Africa¿¿¿
Spain¿¿¿¿¿¿¿¿¿¿
Sweden¿¿¿¿¿¿¿¿¿
Switzerland¿¿¿¿
Taiwan¿¿¿¿¿¿¿¿¿
Trinidad,Tobago
Tunisia¿¿¿¿¿¿¿¿
Turkey¿¿¿¿¿¿¿¿¿
Turkmenistan¿¿¿
U.A.E.¿¿¿¿¿¿¿¿¿
Ukraine¿¿¿¿¿¿¿¿
United¿Kingdom¿
Uruguay¿¿¿¿¿¿¿¿
Uzbekistan¿¿¿¿¿
Vietnam¿¿¿¿¿¿¿¿
|
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
510(K) Database |
510(K)s with Product Code = MSW and Original Applicant = DIAGNOSTIC PRODUCTS CORP.
|